Difference between revisions of "Accounting Finance:Bellegrove-Special Agreement"
Jump to navigation
Jump to search
m |
m |
||
| Line 3: | Line 3: | ||
[[User:Nancyn|Nancyn]] ([[User talk:Nancyn|talk]]) 15:09, 18 August 2016 (PDT) |
[[User:Nancyn|Nancyn]] ([[User talk:Nancyn|talk]]) 15:09, 18 August 2016 (PDT) |
||
| − | == |
+ | ==Contact== |
*Kari Northquist (accounting) [mailto:kari.northquist@bellegrovemedical.com kari.northquist@bellegrovemedical.com] |
*Kari Northquist (accounting) [mailto:kari.northquist@bellegrovemedical.com kari.northquist@bellegrovemedical.com] |
||
**Tel: 1-425-869-7338 ext 117 |
**Tel: 1-425-869-7338 ext 117 |
||
| − | *Mark Holzemer [mailto:mark@bgms.com mark@bgms.com] |
||
Revision as of 15:23, 18 August 2016
Overview
Bellegrove Medical (11988) has shareholder pricing and a special arrangement with uniPHARM. They will transfer funds via vendor transfer without a remittance advice. Look for the payment on daily CIBC Statement of Account Activity Report. They will pay the total value of the invoices less $15 (banking charges) which is paid by uniPHARM. Nancyn (talk) 15:09, 18 August 2016 (PDT)
Contact
- Kari Northquist (accounting) kari.northquist@bellegrovemedical.com
- Tel: 1-425-869-7338 ext 117